Home
COLL
COLL News

Latest Collegium Pharmaceutical Inc. (COLL) News on October 10, 2025

Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders?

Simply Wall St.

9 days ago

Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders?

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Zacks

17 days ago

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Zacks

17 days ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Argus Research

4 months ago

COLL: Raising target price to $32.00

1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar

StockStory

4 months ago

1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar

Argus Research

4 months ago

COLL: Rating decreased to a HOLD

COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities

StockStory

4 months ago

COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities

3 of Wall Street’s Favorite Stocks with Mounting Challenges

StockStory

4 months ago

3 of Wall Street’s Favorite Stocks with Mounting Challenges

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers

StockStory

4 months ago

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers

1 Stock Under $50 with Exciting Potential and 2 to Turn Down

StockStory

4 months ago

1 Stock Under $50 with Exciting Potential and 2 to Turn Down

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

StockStory

5 months ago

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

Argus Research

5 months ago

COLL: What does Argus have to say about COLL?

Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings

Simply Wall St.

5 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Collegium to Participate in Upcoming Investor Conferences

3 Small-Cap Stocks Facing Headwinds

StockStory

5 months ago

3 Small-Cap Stocks Facing Headwinds

Argus Research

5 months ago

COLL: Rating increased to a BUY

MT Newswires

5 months ago

Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies

Collegium Announces $25 Million Accelerated Share Repurchase Program

GlobeNewswire

5 months ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

GuruFocus.com

5 months ago

Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations

StockStory

5 months ago

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations

Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics

Zacks

5 months ago

Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Zacks

5 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Associated Press Finance

5 months ago

Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

GlobeNewswire

5 months ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

5 months ago

Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings

Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect

StockStory

5 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect

Argus Research

5 months ago

COLL: Lowering target price to $28.00

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

5 months ago

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

3 Healthcare Stocks That Concern Us

StockStory

5 months ago

3 Healthcare Stocks That Concern Us

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire

6 months ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Zacks

6 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Argus Research

6 months ago

COLL: What does Argus have to say about COLL?

Argus Research

6 months ago

COLL: Raising target price to $28.00

2 Reasons to Watch COLL and 1 to Stay Cautious

StockStory

6 months ago

2 Reasons to Watch COLL and 1 to Stay Cautious

Argus Research

6 months ago

COLL: Lowering target price to $27.00

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

Simply Wall St.

6 months ago

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory

6 months ago

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

Argus Research

6 months ago

COLL: Lowering target price to $31.00

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

6 months ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

GlobeNewswire

6 months ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

GlobeNewswire

6 months ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Argus Research

6 months ago

COLL: Raising target price to $32.00

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory

7 months ago

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

7 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

GlobeNewswire

7 months ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

MT Newswires

7 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $313,413, According to a Recent SEC Filing

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

GlobeNewswire

7 months ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Simply Wall St.

7 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Argus Research

7 months ago

COLL: Lowering target price to $29.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

7 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

7 months ago

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Simply Wall St.

7 months ago

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

7 months ago

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Collegium Pharmaceutical Inc Earnings Call

GuruFocus.com

7 months ago

Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

7 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Zacks

7 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Associated Press Finance

7 months ago

Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

StockStory

7 months ago

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire

7 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

7 months ago

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

StockStory

7 months ago

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

GuruFocus.com

7 months ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings

Argus Research

7 months ago

COLL: Lowering target price to $30.00

Argus Research

8 months ago

COLL: Lowering target price to $31.00

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

GlobeNewswire

8 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Appoints Nancy S. Lurker to its Board of Directors

GlobeNewswire

8 months ago

Collegium Appoints Nancy S. Lurker to its Board of Directors

Argus Research

8 months ago

COLL: Lowering target price to $32.00

Argus Research

8 months ago

COLL: Lowering target price to $34.00

Argus Research

9 months ago

COLL: What does Argus have to say about COLL?

MT Newswires

9 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $908,628, According to a Recent SEC Filing

MT Newswires

9 months ago

Needham Upgrades Collegium Pharmaceutical to Buy From Hold, Price Target is $46

Collegium Pharmaceutical Unveils 2025 Financial Projections

TipRanks

9 months ago

Collegium Pharmaceutical Unveils 2025 Financial Projections

MT Newswires

9 months ago

Collegium Pharmaceutical Shares Rise After 2025 Guidance

Collegium Provides 2025 Financial Guidance and Business Update

GlobeNewswire

9 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Simply Wall St.

10 months ago

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Argus Research

10 months ago

COLL: Lowering target price to $31.00

Argus Research

10 months ago

COLL: What does Argus have to say about COLL?

Argus Research

10 months ago

COLL: What does Argus have to say about COLL?

Argus Research

10 months ago

COLL: Lowering target price to $32.00

Argus Research

10 months ago

COLL: Raising target price to $33.00

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.

a year ago

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Zacks

a year ago

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Argus Research

a year ago

COLL: Lowering target price to $33.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

a year ago

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Zacks

a year ago

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Zacks

a year ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Zacks

a year ago

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Associated Press Finance

a year ago

Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Reports Record Third Quarter 2024 Financial Results

GlobeNewswire

a year ago

Collegium Reports Record Third Quarter 2024 Financial Results

Collegium Appoints Vikram Karnani as Chief Executive Officer

GlobeNewswire

a year ago

Collegium Appoints Vikram Karnani as Chief Executive Officer

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

GuruFocus.com

a year ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

Argus Research

a year ago

COLL: Lowering target price to $35.00

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

a year ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Zacks

a year ago

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Zacks

a year ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswire

a year ago

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks

a year ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Share on Social Networks: